Randomized Clinical Trial of Long-Acting Oxytetracycline, Foot Trimming, and Flunixine Meglumine on Time to Recovery in Sheep with Footrot

被引:74
|
作者
Kaler, J. [1 ]
Daniels, S. L. S. [1 ]
Wright, J. L. [1 ]
Green, L. E. [1 ]
机构
[1] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England
基金
英国生物技术与生命科学研究理事会;
关键词
Antibacterials; Dichelobacter nodosus; Infectious disease; Ovine; VIRULENT FOOTROT; OVINE; LAMENESS; RECOGNITION; MANAGEMENT;
D O I
10.1111/j.1939-1676.2009.0450.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Internationally, foot trimming is used by most farmers, and parenteral antibacterials by some, to treat sheep with footrot. Nonsteroidal anti-inflammatory drugs (NSAID) are sometimes used. No clinical trials have compared these treatments. Objectives To investigate the above treatments on time to recovery from lameness and foot lesions in sheep with footrot. Animals Fifty-three sheep with footrot on a commercial farm in England. Methods In a randomized factorial design, the sheep were allocated to 6 treatment groups. The treatments were oxytetracycline spray to all sheep (positive control) and one or more of parenteral administration of long-acting oxytetracycline, flunixine meglumine, and foot trimming on day 1 or 6 of diagnosis. Follow-up was for 15 days. Time to recovery from lameness and lesions was investigated with discrete-time survival models. Results There was significant association (P < .05) between recovery from lameness and lesions. Sheep receiving antibacterials parenterally recovered faster from lameness (odds ratio [OR]: 4.92 [1.20-20.10]) and lesions (OR: 5.11 [1.16-22.4]) than positive controls, whereas sheep foot trimmed on day 1 (lameness-OR: 0.05 [0.005-0.51]; lesions-OR: 0.06 [0.008-0.45]) or day 6 of diagnosis (lameness-OR: 0.07 [0.01-0.72]; lesions-OR: 0.07 [0.01-0.56]) recovered more slowly than positive controls. NSAID had no significant effect on recovery. Conclusions and Clinical Importance If foot trimming on day 1 or 6 of diagnosis was stopped and parenteral antibacterials were used, then over 1 million sheep/annum lame with footrot in the United Kingdom would recover more rapidly with benefits to productivity. Globally, this figure would be much higher.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 48 条
  • [41] Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
    Alphs, Larry
    Bossie, Cynthia A.
    Sliwa, Jennifer K.
    Ma, Yi-Wen
    Turner, Norris
    ANNALS OF GENERAL PSYCHIATRY, 2011, 10
  • [42] A multi-center, randomized controlled clinical trial of the application of a shortened protocol of long-acting Triptorelin down-regulated prior to IVF/ICSI among patients with endometriosis: A protocol
    Huijuan Kong
    Linli Hu
    Ling Nie
    Xiaona Yu
    Wei Dai
    Jing Li
    Caihong Chen
    Zhiqin Bu
    Hao Shi
    Qiongfang Wu
    Yichun Guan
    Yingpu Sun
    Reproductive Health, 15
  • [43] Time to Long-Acting Reversible Contraceptive Uptake Over Twelve Months Postpartum: Findings of the Yam Daabo Cluster Randomized-Controlled Trial in Burkina Faso and the Democratic Republic of the Congo
    Coulibaly, Abou
    Millogo, Tieba
    Baguiya, Adama
    Nguyen Toan Tran
    Thieba, Blandine
    Seuc, Armando
    Cuzin-Kihl, Asa
    Landoulsi, Sihem
    Kiarie, James
    Yodi, Rachel
    Mashinda, Desire
    Kouanda, Seni
    OPEN ACCESS JOURNAL OF CONTRACEPTION, 2021, 12 : 73 - 82
  • [44] Effect of Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, on Gastrointestinal Transit Time and Motility in Patients With Short Bowel Syndrome: Findings From a Randomized Trial
    Hvistendahl, Mark Krogh
    Naimi, Rahim Mohammad
    Enevoldsen, Lotte Hahn
    Madsen, Jan Lysgaard
    Fuglsang, Stefan
    Jeppesen, Palle Bekker
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2020, 44 (08) : 1535 - 1544
  • [45] Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial
    Larry Alphs
    Cynthia A Bossie
    Jennifer K Sliwa
    Yi-Wen Ma
    Norris Turner
    Annals of General Psychiatry, 10
  • [46] Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable paliperidone palmitate versus oral antipsychotics
    Wang, Chencai
    Tishler, Todd A.
    Oughourlian, Talia
    Nuechterlein, Keith H.
    de la Fuente-Sandoval, Camilo
    Ellingson, Benjamin M.
    SCHIZOPHRENIA RESEARCH, 2023, 255 : 222 - 232
  • [47] Inhaled Corticosteroids Alone and in Combination With Long-Acting β2 Receptor Agonists to Treat Reduced Lung Function in Preterm-Born Children: A Randomized Clinical Trial (vol 176, pg 133, 2022)
    Goulden, N.
    Cousins, M.
    Hart, K.
    JAMA PEDIATRICS, 2023, 177 (02) : 213 - 213
  • [48] Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension
    Weiss, Margaret D.
    Cutler, Andrew J.
    Kollins, Scott H.
    Donnelly, Graeme A. E.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2021, 31 (09) : 610 - 622